In this article, the four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved.
The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference / Pierce, Raymond J.; Macdougall, Jane; Leurs, Rob; Costi, Maria Paola. - In: TRENDS IN PARASITOLOGY. - ISSN 1471-4922. - 33:8(2017), pp. 581-583. [10.1016/j.pt.2017.04.007]
The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference
Costi, Maria Paola
2017
Abstract
In this article, the four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Trends in parasitology.pdf
Accesso riservato
Descrizione: Articolo principale
Tipologia:
Versione pubblicata dall'editore
Dimensione
540.45 kB
Formato
Adobe PDF
|
540.45 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
